APLEVO Trademark

Trademark Overview

On Wednesday, August 25, 2010, a trademark application was filed for APLEVO with the United States Patent and Trademark Office. The USPTO has given the APLEVO trademark a serial number of 85115651. The federal status of this trademark filing is ABANDONED - EXPRESS as of Friday, March 18, 2011. This trademark is owned by Eli Lilly and Company. The APLEVO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood disorders, cancer, cardiovascular diseases, cholesterol disorders, central nervous system diseases and disorders, diabetes, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, reproductive system diseases and disorders, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders; antipsychotics; antidepressants; anxiety spectrum disorders; atherosclerosis; Alzheimer's; pharmaceutical preparations for use in the treatment of diabetes; pharmaceutical preparations for use in the treatment of rheumatoid arthritis; pharmaceutical preparations f...
aplevo

General Information

Serial Number85115651
Word MarkAPLEVO
Filing DateWednesday, August 25, 2010
Status601 - ABANDONED - EXPRESS
Status DateFriday, March 18, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood disorders, cancer, cardiovascular diseases, cholesterol disorders, central nervous system diseases and disorders, diabetes, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, reproductive system diseases and disorders, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders; antipsychotics; antidepressants; anxiety spectrum disorders; atherosclerosis; Alzheimer's; pharmaceutical preparations for use in the treatment of diabetes; pharmaceutical preparations for use in the treatment of rheumatoid arthritis; pharmaceutical preparations for use in the treatment of Crohn's disease, systemic lupus erythematosus, and ankylosing spondylitis disease; pharmaceutical preparations for use in the treatment of psoriasis and psoriatic arthritis; pharmaceutical preparations for use in the treatment of autoimmune disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 30, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Friday, March 18, 2011ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Friday, March 18, 2011ABANDONMENT - EXPRESS MAILED
Thursday, March 17, 2011TEAS EXPRESS ABANDONMENT RECEIVED
Thursday, October 28, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 28, 2010NON-FINAL ACTION E-MAILED
Thursday, October 28, 2010NON-FINAL ACTION WRITTEN
Wednesday, October 20, 2010ASSIGNED TO EXAMINER
Monday, August 30, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 28, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

aplevo disorders diseases preparations pharmaceutical treatment anxiety diabetes system urological dyslipidemia